Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-371-0 | CAS number: 92044-91-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 12 Jul - 9 Aug 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- adopted in 1982
- Deviations:
- yes
- Remarks:
- no analytical purity reported
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 130905-60-1
- EC Number:
- 603-445-4
- Cas Number:
- 130905-60-1
- IUPAC Name:
- 130905-60-1
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Wistar Albino rats of the Crl: Wi/Br strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH (Laboratory Animal Breeding), Sulzfeld, Germany
- Age at study initiation: about 6 weeks
- Weight at study initiation: 121-152 g (males); 123-143 g (females)
- Housing: individual in Makrolon type II cages, bedding was produced from pure soft wood, dried, freed from dust and sterilized at 180 °C.
- Diet: “Ssniff R” diet in pellet form (laboratory standard rat diet), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.5 ± 1.5
- Humidity (%): 60 ±10
- Air changes (per hr): 16 times per hour
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test material was diluted with corn oil to give the final concentrations. For this purpose, the test material was heated to about 70°C to liquefy the test article and appropriate amounts were weighed and mixed with corn oil in volume/volume proportions.
VEHICLE
- Concentration in vehicle: 2.0, 20.0 and 50%
- Amount of vehicle (if gavage): 10 mL - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The stability of the test material was determined in the vehicle prior to the initiation of the study. In fact a 20% suspension of the test article was analysed at preparation and 2, 4 and 24 hours thereafter.
Analytical results indicated that the dosing suspensions were stable for at least 24 hours.
These analyses provided information on the homogeneity of the test item in suspension as well.
The concentration and identity of the dosing solutions were determined at the start and at the end of the study. All values obtained were in reasonable accordance with the nominal values. - Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- once daily, 7 days/week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.2 other: mL/kg bw/day
- Remarks:
- actual ingested
- Dose / conc.:
- 2 other: mL/kg bw/day
- Remarks:
- actual ingested
- Dose / conc.:
- 5 other: mL/kg bw/day
- Remarks:
- actual ingested
- Dose / conc.:
- 180 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 800 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 4 500 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Dose levels used in the present study were chosen on the basis of results obtained during a 7-day range finding study. A dosage of 5 mL/kg bw was used and did not cause overt signs of toxicity. On the basis of these results, 5 mL/kg bw was selected as the highest dose in the present study with the purpose to get information on target organ toxicity. The low and mid doses were chosen in order to obtain a clear no adverse effect level.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Clinical observations were conducted daily. Mortality checks were performed twice daily.
- Cage side observations checked in table [animals´ sensory and motor behaviour, coat, body orifices, urine, feces and general health status] were included.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Special clinical examinations were conducted prior to study initiation (week 0) and thereafter on week 2 and 4.
BODY WEIGHT: Yes
- Time schedule for examinations: Measurements of body weight were made at weekly intervals.
FOOD CONSUMPTION AND COMPOUND INTAKE:
- Time schedule for examinations: at weekly intervals
- Food conversion ratio was calculated from the change in weight and the food consumption over the same periods of time: Yes
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: cornea, episcleral vessels, anterior chamber, pupil, lens and, if possible, retina were examined with a slit lamp and an ophthalmoscope fitted with a selection of lenses prior to study initiation (week 0) and thereafter on week 2 and 4.
- Dose groups that were examined: on male and female rats of each test group.
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at the end of the administration period
- Anaesthetic used for blood collection: No
- Animals fasted: No data
- How many animals: on male and female rats of each test group
- Parameters examined: erythrocytes (RBC), leukocytes (WBC), thrombocytes, haemoglobin, hematocrit, MCV, MCH and MCHC, differential blood count, reticulocytes, inclusion bodies, prothrombin time
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at the end of the administration period
- Animals fasted: No
- How many animals: on male and female rats of each test group
- Parameters examined: Glucose, triglyceride, cholesterol, protein (total), albumin, bilirubin (total), creatinine, urea nitrogen (BUN), uric acid, calcium, chloride, inorg. Phosphorus, iron, potassium, sodium, Na/K ratio by statistical evaluation, alanine aminotransferase (ALT), alkaline phosphatase, aspartate aminotransferase (AST), creatinine kinase (CK), glutamate dehydrogenase (GLDH), AST/ALT ratio by statistical evaluation
URINALYSIS: Yes
- Time schedule for collection of urine: at the end of the administration period
- Metabolism cages used for collection of urine: No
- Animals fasted: No
- Parameters examined: color, protein, pH value, glucose, bilirubin, urobilinogen, blood, nitrite, ketones, sediment, specific gravity
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: prior to study initiation (week 0) and thereafter on week 2 and 4.
- Dose groups that were examined: on male and female rats of each test group
- Battery of functions tested: hearing activity (tested by simple noise production) - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes. All animals were sacrificed at the end of the experimental phase by CO2 asphyxiation. Rapid exsanguination was carried out by cutting the A.carotis. The following organs were examined: cranial, thoracic, abdominal and pelvis cavities.
HISTOPATHOLOGY: Yes. A complete histopathological examination was performed on all male and female animals of control group and high dose group on the following organs: adrenals (2x), heart, kidneys (2x), liver, spleen, prostate. - Other examinations:
- The following organ weights were determined: liver, kidneys, adrenals, spleen, prostate gland, uterus, testes (left and right) with epididymides
- Statistics:
- Statistical analyses were performed separately on data from male and female animals. One or two-factorial analysis of variance was conducted on weight changes and food consumption. Group means were compared by the “Scheffe´” test.
Organ weights were evaluated by analysis of covariance and the mean values were compared by the “Scheffe´” test of covariance.
Values form chemical chemistry and hematology were analysed by analysis of variance with subsequent the “Scheffe´” test of variance.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- significant increase in prostate weight in high dose animals. However, this increase was not attended by any histopathologcal changes.
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- HISTOPATHOLOGY
All histopathological findings noted in the study were considered to be unrelated to the administration of the test article.
CLINICAL SIGNS
There were no deviations from normal in any group. All animals showed a healthy habit and behaviour throughout the study.
Reflex, ophthalmoscopic and auditory examinations revealed no findings related to the administration of the test article.
In individual animals the righting reflex was slightly reduced. This finding was attributed to coincidence, since there was no evidence of a dose-relationship.
PRE-TERMINAL DEATHS
No pre-terminal deaths occurred during the test period.
BODY WEIGHT DEVELOPMENT, FOOD CONSUMPTION AND FOOD CONVERSION RATIO
Body weights, food consumption and food conversion ratio were comparable to the controls and there were no significant intergroup differences.
HEMATOLOGY
All mean values were within the limits of the respective normal range. Hence the test article administration did not influence hematology parameters in any group.
CLINICAL CHEMISTRY
Clinical chemistry parameters did not reveal any changes which were connected with test article administration. The only significant difference was a slightly reduced total bilirubin content in high dose male animals compared to the respective control animals. Since this slight decline was without dose-relation and within the limits of the normal range, it is not considered biologically relevant and is attributed to coincidence.
URINALYSIS
The results of urinalysis gave no indication of treatment-related changes in any group. All findings were within the respective normal range and comparable to the controls.
NECROPSY - MACROSCOPIC FINDINGS
There were no macroscopic changes which were connected with test article administration.
ORGAN WEIGHTS
The only significant finding was an increase in prostate weight in high dose males. In amendment to the original study protocol this organ was therefore subjected to histo pathological examination.
Since nothing abnormal was found microscopically in this organ, the weight increase of prostates in high dose males may be considered either a coincidental finding or a result of a test article induced load reaction without histopathological manifestation.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 1 800 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Under the experimental conditions of this study a daily oral administration of 1800 mg/kg bw/day had no adverse effects on rats after 4 weeks
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)